ProtaGene is a world leading CRO partner for the gene and cell therapy industries.

From discovery to product commercialization, ProtaGene provides the most advanced, integrated, and complete protein and gene analytic capabilities and packages for cell & gene therapy platforms.

A unique combination of gene- and protein based analytical platforms provides our clients unique expertise for cell & gene therapy and biologics development for MLA and BLA submission. The organization operates four sites in Europe and North America and works in advanced therapeutic platforms with leading biopharmaceutical and gene therapy companies worldwide.